AH
Abdul Hamid War
About Abdul Hamid War
Data last updated:
Abdul Hamid War is a Director at Spenduo Pharmaceuticals Private Limited (since 2019) and Designated Partner at Arance India Pharmaceuticals Llp (since 2021). The companies operate in Food And Beverages and Chemicals. The largest current company by reported revenue is Spenduo Pharmaceuticals Private Limited at ₹39.2 Lakh (FY 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Spenduo Pharmaceuticals Private Limited U24304GJ2019PTC109136 | Director | 17 Jul 2019 | 2019 | ₹39.2 Lakh (FY 2020) | Active |
| Arance India Pharmaceuticals Llp AAZ-8372 | Designated Partner | 10 Dec 2021 | 2021 | Active |
Board colleagues of Abdul Hamid War
| Name | DIN | Company | Designation |
|---|---|---|---|
| Riyaz Ahmad Riyazi | 08898039 | Spenduo Pharmaceuticals Private Limited | Additional Director |
| Zahoor Ganie | 08720103 | Spenduo Pharmaceuticals Private Limited , Arance India Pharmaceuticals Llp | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Abdul Hamid War
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abdul Hamid War
Abdul Hamid War currently holds 2 directorships: Spenduo Pharmaceuticals Private Limited (Director, since 17 Jul 2019, revenue ₹39.2 Lakh (FY 2020)); Arance India Pharmaceuticals Llp (Designated Partner, since 10 Dec 2021).
Abdul Hamid War was first appointed on 17 Jul 2019 as Director at Spenduo Pharmaceuticals Private Limited. The most recent appointment on record is 10 Dec 2021 at Arance India Pharmaceuticals Llp.
The current boards of Abdul Hamid War's companies include Riyaz Ahmad Riyazi (Spenduo Pharmaceuticals Private Limited), Zahoor Ganie (Spenduo Pharmaceuticals Private Limited).